You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 9.0% | n/a |
| ROCE | 10.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 39.6 | 0.0 |
| PEG | 0.3 | -999,999.0 |
| Price / Revenue | 4.0 | 0.0 |
| Price / Book value | 4.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.1% | 0.0% |
| PBT | 132.4% | n/a |
| EPS | 119.6% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | 3.27 | -2.87 | -8.70p | -2.9 | 0.0 | n/a | n/a | 0.0% |
| 2017-09-30 | 4.10 | -1.91 | -5.70p | -5.9 | 0.0 | n/a | n/a | 0.0% |
| 2018-09-30 | 5.39 | -0.79 | -2.00p | -13.5 | 0.0 | n/a | n/a | 0.0% |
| 2019-09-30 | 7.56 | 0.37 | 0.92p | 55.4 | 0.0 | n/a | n/a | 0.0% |
| 2020-09-30 | 9.53 | 0.86 | 2.02p | 48.0 | 0.4 | 120% | n/a | 0.0% |
| Ixico secures new contract valued at more than $750,000 Sharecast News | 22 Sep |
|---|---|
| Ixico awarded phase 1 clinical trial contract Sharecast News | 08 Sep |
| Ixico confident as full-year revenue, earnings decline Sharecast News | 06 Aug |
| New contract worth >$750k | 22-Sep-21 07:00 |
|---|---|
| Phase II HD contract with new client worth >$500K | 20-Sep-21 07:00 |
| Phase I MSA contract award worth >$500k | 08-Sep-21 07:00 |
| Trading Update | 06-Aug-21 07:00 |
| Issue of Equity | 23-Jun-21 15:32 |